Skip to content
Search

Latest Stories

Weight-loss injections can cause gallstones, warns pharmacist

An increasing number of patients taking weight-loss injections are having their gallbladders removed, the pharmacist said.

More patients on weight-loss injections undergoing gallbladder removal, warns pharmacist

Weight-loss injections can make bile more sludgy and even lead to the formation of gallstones

GettyImages

A leading pharmacist has raised concerns over a rise in gallbladder issues among individuals using weight-loss injections, particularly Eli Lilly’s Mounjaro (tirzepatide).

Deborah Grayson, a pharmacist and nutritional therapist, shared an alert in a TikTok video, highlighting the potential effects of weight-loss injections on gallbladder health.


“I'm seeing more and more patients taking weight-loss injections who then need their gallbladders removed,” she said.

Grayson, known as The Godmother of Pharmacology, explained how these drugs increased the risk of gallstone formation.

“The injections slow down the flow of bile through the gallbladder and delay emptying by suppressing the release of the hormone that controls it.

“This is one of the key ways in which it works. Unfortunately, this can also mean that in some people, this can make bile more sludgy and even lead to the formation of gallstones,” she warned.

According to Grayson, the risk of gallstone development could be as high as 1 in 10 people taking these drugs.

Deborah Grayson LinkedIn

Eli Lilly has already acknowledged gallbladder-related side effects in its safety warnings for Mounjaro, which is an injectable prescription medicine originally developed to manage blood sugar in adults with type 2 diabetes.

It is also authorised for use in weight loss and weight management in adults aged 18 and over, alongside a reduced-calorie diet and increased physical activity.

“Gallbladder problems have happened in some people who use Mounjaro,” the company said.

The company also listed other serious potential side effects, including:

  • Thyroid tumors, including thyroid cancer
  • Pancreatitis (inflammation of the pancreas)
  • Hypoglycemia (low blood sugar)
  • Severe allergic reactions
  • Kidney failure
  • Serious stomach issues
  • Changes in vision

These problemshave also been associated with Wegovy (semaglutide), produced by Novo Nordisk.

Beware of the risk factors of gallstones

Grayson also highlighted other risk factors that could increase the risk of developing gallstones. These include being women, thyroid disease, menopausal or perimenopausal, and rapid weight loss.

“If any of these apply to you, it's important to look out for the signs that your gallbladder is struggling,” she said.

In a follow-up social media post, Grayson said that high cholesterol and poorly managed blood sugar are also risk factors and warned that “the more of these that apply the greater the risk.”

Symptoms of gallstones

Grayson advises patients taking the injections to be aware of the early warning signs of gallstones or sludgy bile that can lead to the stones forming. These include:

  • Acid reflux
  • Trapped wind and burping
  • Pain below the ribs
  • Left-sided shoulder pain
  • Abdominal pain
  • Diarrhoea or to a lesser extent constipation
  • Pale, greasy floaty stools
  • Bowel urgency

Patients experiencing these symptoms should seek medical advice promptly.

Before using weight loss jabs, it is advisable to inform your healthcare provider about any medical conditions you have and any medications you are taking to help prevent serious side effects.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less